Carregant...
The Heterogeneity of Prostate Cancers Lacking AR Activity Will Require Diverse Treatment Approaches
The use of androgen deprivation therapy and second line anti-androgens in prostate cancer has led to the emergence of tumors employing multiple androgen receptor (AR)-dependent and AR-independent mechanisms to resist AR targeted therapies in castration-resistant prostate cancer (CRPC). While the AR...
Guardat en:
| Publicat a: | Endocr Relat Cancer |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8292199/ https://ncbi.nlm.nih.gov/pubmed/33792558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-21-0002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|